Regional Heterogeneity of Decreased Myocardial Norepinephrine and Increased Lipid Peroxidation Levels in Patients With End-stage Failing Heart Secondary to Dilated or Ischemic Cardiomyopathy

Journal of Heart and Lung Transplantation

Volumn 27, Issue 7, 2008, Pages 767-774

  Rochette, Luc ^a   Tatou, Etienne ^a   Vergely, Catherine ^a   Maupoil, Véronique ^a   Bouchot, Olivier ^a   Mossiat, Claude ^a   Jazayeri, Sahed ^a   Benkhadra, Salima ^a   Brenot, Roger ^a   Girard, Claude ^a   David, Michel ^a  

^a DIJON UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

NORADRENALIN; THIOBARBITURIC ACID;

ADULT; ARTICLE; CARDIOMYOPATHY; CLINICAL ARTICLE; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; FEMALE; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE BIOPSY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HISTOPATHOLOGY; HUMAN; LIPID PEROXIDATION; MALE; PRIORITY JOURNAL;

BIOPSY; CARDIOMYOPATHY, DILATED; FEMALE; HEART FAILURE; HUMANS; LIPID PEROXIDATION; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; MYOCARDIUM; NOREPINEPHRINE; SEVERITY OF ILLNESS INDEX;

EID: 45549086544     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healun.2008.03.025     Document Type: Article

References (28)

1. Beltrami C.A., Finato N., Rocco M., et al. The cellular basis of dilated cardiomyopathy in humans. J Mol Cell Cardiol 27 (1995) 291-305
2. Chidsey C.A., Braunwald E., Morrow A.G., et al. Myocardial norepinephrine concentration in man. Effects of reserpine and of congestive heart failure. N Engl J Med 269 (1963) 653-658
3. Ungerer M., Hartmann F., Karoglan M., et al. Regional in vivo and in vitro characterization of autonomic innervation in cardiomyopathic human heart. Circulation 97 (1998) 174-180
4. Amin J.K., Xiao L., Pimental D.R., et al. Reactive oxygen species mediate alpha-adrenergic receptor-stimulated hypertrophy in adult rat ventricular myocytes. J Mol Cell Cardiol 33 (2001) 131-139
5. Ide T., Tsutsui H., Kinugawa S., et al. Direct evidence for increased hydroxyl radicals originating from superoxide in the failing myocardium. Circ Res 86 (2000) 152-157
6. Dieterich S., Bieligk U., Beulich K., et al. Gene expression of antioxidative enzymes in the human heart: increased expression of catalase in the end-stage failing heart. Circulation 101 (2000) 33-39
7. Jarreta D., Orus J., Barrientos A., et al. Mitochondrial function in heart muscle from patients with idiopathic dilated cardiomyopathy. Cardiovasc Res 45 (2000) 860-865
8. Gonzalez A., Fortuno M.A., Querejeta R., et al. Cardiomyocyte apoptosis in hypertensive cardiomyopathy. Cardiovasc Res 59 (2003) 549-562
9. Anversa P., Leri A., Beltrami C.A., et al. Myocyte death and growth in the failing heart. Lab Invest 78 (1998) 767-786
10. Rochette L., Moreau D., and Opie L.H. Effect of repeated regional mycardial ischemia in the rat heart on reperfusion arrhythmias and release of norepinephrine. J Cardiovasc Pharmacol 38 (2001) 78-89
11. Dalloz F., Maingon P., Cottin Y., et al. Effects of combined irradiation and doxorubicin treatment on cardiac function and antioxidant defenses in the rat. Free Radic Biol Med 26 (1999) 785-800
12. Pierpont G.L., DeMaster E.G., Reynolds S., et al. Ventricular myocardial catecholamines in primates. J Lab Clin Med 106 (1985) 205-210
13. Regitz V., and Fleck E. Myocardial adenine nucleotide concentrations and myocardial norepinephrine content in patients with heart failure secondary to idiopathic dilated or ischemic cardiomyopathy. Am J Cardiol 69 (1992) 1574-1580
14. Regitz V., Sasse S., Bossaller C., et al. Myocardial catecholamine content in heart failure-I: Regional distribution in explanted hearts. Comparison between dilated cardiomyopathy and coronary heart disease. J Cardiol 78 (1989) 751-758
15. Regitz V., Sasse S., and Fleck E. Myocardial catecholamine content in heart failure-II: Measurement in endomyocardial biopsies, reference systems, normal values. J Cardiol 78 (1989) 759-763
16. Regitz V., Bossaller C., Strasser R., et al. Myocardial catecholamine content after heart transplantation. Circulation 82 (1990) 620-623
17. Kramer C.M., Reichek N., Ferrari V.A., et al. Regional heterogeneity of function in hypertrophic cardiomyopathy. Circulation 90 (1994) 186-194
18. Heng M.K., Janz R.F., and Jobin J. Estimation of regional stress in the left ventricular septum and free wall: an echocardiographic study suggesting a mechanism for asymmetric septal hypertrophy. Am Heart J 110 (1985) 84-90
19. Schafers M., Dutka D., Rhodes C.G., et al. Myocardial presynaptic and postsynaptic autonomic dysfunction in hypertrophic cardiomyopathy. Circ Res 82 (1998) 57-62
20. Momose M., Tyndale-Hines L., Bengel F.M., et al. How heterogeneous is the cardiac autonomic innervation?. Basic Res Cardiol 96 (2001) 539-546
21. Perrone-Filardi P., Bacharach S.L., Dilsizian V., et al. Regional systolic function, myocardial blood flow and glucose uptake at rest in hypertrophic cardiomyopathy. Am J Cardiol 72 (1993) 199-204
22. Maack C., Tanja K., Heiko K., et al. Oxygen free radical release in human failing myocardium is associated with increased activity of Rac1-GTPase and represents a target for statin treatment. Circulation 108 (2004) 1567-1574
23. Dalloz F., Maingon P., Cottin Y., et al. Effects of combined irradiation and doxorubicin treatment on cardiac function and antioxidant defenses in the rat. Free Radic Biol Med 26 (1999) 785-800
24. Conti M., Renaud I.M., Poirier B., et al. High levels of myocardial antioxidant defense in aging nondiabetic normotensive Zucker obese rats. Am J Physiol 286 (2004) 793-800
25. Strauer B.E. Significance of coronary circulation in hypertensive heart disease for development and prevention of heart failure. Am J Cardiol 65 (1990) 34G-41G
26. Swynghedauw B. Molecular mechanisms of myocardial remodelling. Physiol Rev 79 (1999) 215-262
27. Prestle J., Dieterich S., Preuss M., et al. Heterogeneous transmural gene expression of calcium-handling proteins and natriuretic peptides in the failing human heart. Cardiovasc Res 43 (1999) 323-331
28. Tansley P., Yacoub M., Rimoldi O., et al. Effects of left ventricular assist device combination therapy on myocardial blood flow in patients with end-stage dilated cardiomyopathy. J Heart Lung Transplant 23 (2004) 1283-1289